2. Sino-American Shanghai Squibb Pharmaceutical Co., Ltd. and Shanghai Roche Pharmaceutical Factory.
3. Foreign-funded enterprises are independent economic entities, operating independently, accounting independently and bearing legal responsibilities independently. As far as organizational forms are concerned, foreign-funded enterprises can be legal persons or non-legal persons. A foreign-funded enterprise with legal personality has obtained legal personality according to law, and its organizational form is generally a limited liability company. The liability of foreign investors to the enterprise is limited to the amount of their subscribed capital contribution.
Extended data:
1. Sino-American Shanghai Squibb Pharmaceutical Co., Ltd. was established on June 20 14, 5438+0982 65438+1October 41985 65438+1October, and was established by Bristol-Myers Squibb Company of the United States.
1. Sino-American Shanghai Squibb Pharmaceutical Co., Ltd., jointly invested by Bristol-Myers Squibb Company, China Pharmaceutical Foreign Trade Company and Shanghai Pharmaceutical (Group) Corporation, is the first Sino-American joint venture pharmaceutical enterprise established in China.
2. The registered capital of the company is US$ 65,438+US$ 0,654,38+US$ 0,640, the total investment is US$ 29.48 million, and the proportion of Chinese and foreign investment is 40: 60. After continuous expansion and upgrading, the total investment has reached 60 million US dollars.
2. Shanghai Roche Pharmaceutical Co., Ltd. was established in 1994 with a total investment of 62.357 million US dollars. Committed to oncology, virology, transplantation and other key treatment fields, and strive to fundamentally improve people's quality of life.
1. With the establishment of Roche R&D (China) Co., Ltd. at the end of 2004 and the opening of Roche Drug Development China Center in 2007, Roche has established a complete pharmaceutical industry value chain in China, including R&D, production and marketing.
2. In 2008, the expansion project of Roche's factory was started, and the Asian Pharmaceutical Cooperation Department was established in Shanghai, which further reflected Roche's long-term commitment to the development of China. Since September 1 day, 2009, Roche Pharmaceuticals Asia-Pacific Regional Headquarters has settled in Shanghai, and Roche Drug Development China Center has also been upgraded to Roche Drug Clinical R&D Asia-Pacific Center.
3. Roche not only introduced the latest technology and cutting-edge products to China, but also brought the international leading management system.
4. Shanghai Roche invested $3.7 million to launch a customer relationship management (CRM) system representing the highest level in the world. This project won the creative award in the first Asian "One-on-One Creative Pioneer" selection, the "Top Ten Enterprises Implementing Customer Relationship Management System in China" in 2002 and the "Best CRM Implementation Enterprise Award in China" in 2003.
Three. Shanghai General Pharmaceutical Co., Ltd. was incorporated in Shanghai Industrial and Commercial Bureau on October 20th, 2000. The legal representative is Xu Xiaoyang, whose business scope includes the production of small-volume injections, eye drops, hard capsules and ointments.
Four. Wuxi PharmaTech is the world's leading R&D open capability and technology platform company for pharmaceutical, biotechnology and medical devices, providing innovative pharmaceutical R&D services to customers all over the world.
1. Founded in 2000, the company is headquartered in Shanghai, China, and has more than10,000 employees and business entities in China and the United States. As a customer-centric company, Wuxi PharmaTech provides a series of comprehensive laboratory R&D, research and production services for pharmaceutical companies, biotechnology companies and medical device companies around the world, covering the whole process from drug discovery to listing.
2. Wuxi PharmaTech's service aims to help global customers shorten the research and development cycle of drugs and medical devices through cost-effective and efficient integrated research and development services; Reduce research and development costs.
References:
Baidu encyclopedia-Wuxi pharmatech new drug development co., ltd
References:
Baidu Encyclopedia-Shanghai General Pharmaceutical Co., Ltd.
References:
Baidu encyclopedia-Shanghai Roche pharmaceutical co., ltd
References:
Baidu Encyclopedia-Sino-American Shanghai Squibb Pharmaceutical Co., Ltd.